Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy

Francesco Ceppi; Michel Duval; Jean-Marie Leclerc; Caroline Laverdiere; Yves-Line Delva; Sonia Cellot; Pierre Teira; Henrique Bittencourt

doi:10.1371/journal.pone.0160310

Loading metrics

Open Access

Peer-reviewed

Research Article

Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy

Francesco Ceppi,

Affiliation Hemato-Oncology Division, Charles Bruneau Cancer Research Center, CHU Ste-Justine, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada
⨯
Michel Duval,

Affiliation Hemato-Oncology Division, Charles Bruneau Cancer Research Center, CHU Ste-Justine, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada
⨯
Jean-Marie Leclerc,

Affiliation Hemato-Oncology Division, Charles Bruneau Cancer Research Center, CHU Ste-Justine, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada
⨯
Caroline Laverdiere,

Affiliation Hemato-Oncology Division, Charles Bruneau Cancer Research Center, CHU Ste-Justine, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada
⨯
Yves-Line Delva,

Affiliation Hemato-Oncology Division, Charles Bruneau Cancer Research Center, CHU Ste-Justine, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada
⨯
Sonia Cellot,

Affiliation Hemato-Oncology Division, Charles Bruneau Cancer Research Center, CHU Ste-Justine, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada
⨯
Pierre Teira,

Affiliation Hemato-Oncology Division, Charles Bruneau Cancer Research Center, CHU Ste-Justine, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada
⨯
Henrique Bittencourt

* E-mail: henrique.bittencourt.hsj@ssss.gouv.qc.ca

Affiliation Hemato-Oncology Division, Charles Bruneau Cancer Research Center, CHU Ste-Justine, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada
⨯

Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy

Francesco Ceppi,
Michel Duval,
Jean-Marie Leclerc,
Caroline Laverdiere,
Yves-Line Delva,
Sonia Cellot,
Pierre Teira,
Henrique Bittencourt

Published: September 15, 2016
https://doi.org/10.1371/journal.pone.0160310

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Hematopoietic stem cell transplantation
Is the Subject Area "Hematopoietic stem cell transplantation" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Stem cell therapy
Is the Subject Area "Stem cell therapy" applicable to this article?

Thanks for your feedback.
Acute lymphoblastic leukemia
Is the Subject Area "Acute lymphoblastic leukemia" applicable to this article?

Thanks for your feedback.
Leukemia
Is the Subject Area "Leukemia" applicable to this article?

Thanks for your feedback.
Cancer chemotherapy
Is the Subject Area "Cancer chemotherapy" applicable to this article?

Thanks for your feedback.